Aepli Patrick, Criblez Dominique, Baumeler Stephan, Borovicka Jan, Frei Remus
1Gastroenterology and Hepatology Unit, Luzerner Kantonsspital, Lucerne, Switzerland.
Division of Gastroenterology/Hepatology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
United European Gastroenterol J. 2018 Apr;6(3):463-470. doi: 10.1177/2050640617728001. Epub 2017 Aug 23.
Endoscopic full thickness resection (EFTR) by the Full Thickness Resection Device (FTRD) has recently been introduced as a method to allow resection of certain lesions such as adenomatous polyps that would not be resectable by standard polypectomy techniques. We report our clinical experience with FTRD procedures, assessing technical success, completeness of resection (R0 status), rate of histologically proven FTR and safety.
We conducted a retrospective analysis of 33 consecutive patients with colonic polyps treated with FTRD from May 2015 to November 2016.
Indications mainly were adenoma recurrence or residual adenoma with nonlifting sign after previous polypectomy. In the 31 cases amenable to EFTR, resection was en bloc and histologically complete (R0) in 87.9% (29/33) of patients. Histologically confirmed complete full thickness resection (FTR) was achieved in 80.6% (25/31). Three post-procedure bleedings and one perforation were seen.
FTRD offers an additional endoscopic approach to treat nonlifting colorectal lesions. EFTR by FTRD appears to be feasible and efficacious in the resection of benign neoplasms of up to 30 mm in diameter and may be an alternative to surgery in selected patients. Given a significant rate of complications, safety is a concern and needs to be assessed in larger prospective studies.
全层切除装置(FTRD)进行的内镜全层切除术(EFTR)最近被引入,作为一种切除某些病变(如腺瘤性息肉)的方法,这些病变无法通过标准息肉切除术技术切除。我们报告了我们使用FTRD手术的临床经验,评估技术成功率、切除完整性(R0状态)、组织学证实的FTR率和安全性。
我们对2015年5月至2016年11月连续33例接受FTRD治疗的结肠息肉患者进行了回顾性分析。
适应症主要是腺瘤复发或先前息肉切除术后有非抬举征的残留腺瘤。在31例适合EFTR的病例中,87.9%(29/33)的患者切除为整块切除且组织学完整(R0)。组织学证实的全层完整切除(FTR)率为80.6%(25/31)。观察到3例术后出血和1例穿孔。
FTRD为治疗非抬举性结直肠病变提供了另一种内镜方法。FTRD进行的EFTR在切除直径达30毫米的良性肿瘤方面似乎可行且有效,对于选定的患者可能是手术的替代方法。鉴于并发症发生率较高,安全性是一个问题,需要在更大规模的前瞻性研究中进行评估。